Benedito Antônio Lopes da Fonseca

Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy

Dimitrios C. Mastellos, Bruno G. P. Pires da Silva, Benedito Antônio Lopes da Fonseca et al. · Clinical Immunology · 2020 · 256 citations · Full text

Complement System, Differential Biological Efficacy, Covid-19 Pandemic +8

Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial

Eduardo Ramacciotti, Leandro Barile Agati, Daniela Calderaro et al. · The Lancet · 2021 · 245 citations · Full text

Thrombosis, Hematology, Patient Safety +8

Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease

Gustavo Pompermaier Garlet, Walter Martins, Benedito Antônio Lopes da Fonseca et al. · Journal Of Clinical Periodontology · 2004 · 223 citations

Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries

Abdul Rouf Banday, Megan L. Stanifer, Oscar Flórez-Vargas et al. · Nature Genetics · 2022 · 132 citations · Full text

Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis

Steven Pincus, Peter W. Mason, Eiji Konishi et al. · Virology · 1992 · 126 citations

Vaccination, Pathogenesis, Immunology +9